FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

18 letters match. Newest first.

  1. Cue Health, Inc.

    FDA warned Cue Health that it changed its authorized COVID-19 tests without approval and released lots under a weak sampling plan.

    High risk
  2. North American Diagnostics, LLC

    FDA warns North American Diagnostics over unapproved COVID-19 antigen tests and quality system failures.

    High risk
  3. Empowered Diagnostics LLC

    Empowered Diagnostics distributed COVID-19 test kits without FDA approval or emergency authorization, and some labeling falsely said they were authorized.

    High risk
  4. USA Medical LLC

    FDA: USA Medical sold unapproved COVID-19 antigen tests with false EUA claims and lacked basic quality system procedures.

    High risk
  5. W.H.P.M, Inc.

    W.H.P.M. sold unapproved COVID-19 test kits in the U.S. and had quality-system violations.

    High risk
  6. Lusys Laboratories, Inc.

    FDA warned Lusys Laboratories for selling two unapproved COVID-19 test kits in the U.S. without FDA clearance or authorization.

    High risk
  7. DermaCare Biosciences, LTD.

    DermaCare sold an unapproved, misbranded Easy Rapid Now COVID-19 antigen test directly to U.S. consumers, FDA says.

    High risk
  8. Lepu Medical Technology -Beijing- Co., Ltd.

    FDA warns Lepu Medical Technology Beijing that its unapproved COVID-19 test kits are adulterated and misbranded.

    High risk
  9. Biopolygen Corp.

    FDA warned Biopolygen Corp. for selling three unapproved COVID-19 self-test kits directly to consumers online.

    High risk
  10. USH Diagnostics, Inc./covidinstanttest.net

    USH Diagnostics/covidinstanttest.net offered unapproved at-home COVID-19 test kits with misleading FDA authorization claims.

    High risk
  11. Innova Medical Group, Inc.

    Innova Medical Group distributed unapproved COVID-19 antigen tests and had quality-system and labeling violations, FDA says.

    High risk
  12. Baltimore Beauty Security Square Mall

    Baltimore Beauty offered GenBody COVID-19 test kits directly to consumers without FDA approval, clearance, or authorization.

    High risk
  13. Sethi Laboratories

    FDA warned Sethi Laboratories for selling unapproved COVID-19 antibody and antigen self-test kits directly to consumers and falsely claiming FDA authorization.

    High risk
  14. Fast Masks USA LLC

    Fast Masks USA sold unapproved at-home COVID-19 test kits and claimed they were FDA approved or authorized, FDA says.

    High risk
  15. Ikcon Investments, Inc dba Ikcon Medical

    FDA warned Ikcon Medical that it sold unapproved COVID-19 antibody and antigen tests online and made misleading 'FDA registered' claims.

    High risk
  16. Tresmonet Technologies, Inc., TM Testing, Inc. dba TM Technologies, Inc./TM Labs

    FDA warned Tresmonet/TM Labs over selling an unapproved, misbranded at-home COVID-19 antibody test and claiming FDA approval.

    High risk
  17. Block Scientific

    Block Scientific sold two COVID-19 antibody and antigen rapid tests online without FDA approval, clearance, or authorization.

    High risk
  18. Orvic dba Webstore-USA

    Orvic dba Webstore-USA sold an unapproved at-home COVID-19 antibody test online without FDA clearance, making it adulterated and misbranded.

    High risk